论癌症药品专利保护的策略

Strategy of patent protection for anti-cancer drugs

恶性肿瘤作为威胁人类健康的重大疾病之一越来越受到社会的关注。抗肿瘤药物在癌症治疗方面发挥着重要作用,但抗肿瘤药物专利保护形成的患者难以承受的高昂药价与社会公共健康利益的矛盾正日益尖锐。本文从癌症药品的特征、专利保护现状、市场运行机制和利益冲突机制等方面探讨了癌症药品专利保护的策略,为进一步完善癌症药品的专利保护提供了有益的探索。

Malignant tumors, as one of the major diseases that threat to human health, are receiving more and more attentions from the society. Anti-cancer drugs play an important role in the treatment of malignant tumors, but as a result of drug patent protection, it is becoming increasingly sharp conflict between the social health benefits and the exorbitant prices of anti-cancer drugs that are difficult to afford for cancer patients. To study the strategy of patent protection for anticancer drugs, the paper discussed the characteristics of anti-cancer drugs, the status quo of drug patent protection, the mechanism of pharmaceutical market operation, the conflict between drug patent protection and public health benefit etc. It is of significance to further perfect the patent protection for anti-cancer drugs.